Medical information Clinical review pending

Infection Testing

Cryptococcus Antibody Test

Detects antibodies to the Cryptococcus fungus, crucial for diagnosing cryptococcal infections, especially in individuals with weakened immune systems. Early detection aids effective treatment.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: 2 mL (0.5 mL minimum) serum collected in an SST tube.
Results: Confirm with the laboratory before booking.
Preparation: No specific patient preparation is required for this test. Confirm with the laboratory before booking.

Test priceKSh 22,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Cryptococcus Antibody Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Suspected cryptococcal infection
✓Symptoms such as persistent cough, fever, headache, or confusion
✓Immunocompromised patients (e.g., HIV/AIDS, cancer, organ transplant recipients)
✓Monitoring for infection in high-risk populations
✓History of cryptococcal infection

In plain language

What this test helps you understand

This test helps in the diagnosis of cryptococcal infections, particularly in immunocompromised individuals. Early detection allows for timely treatment initiation, potentially improving patient outcomes and reducing morbidity associated with the infection.

The Cryptococcus Antibody Test is a diagnostic tool used to identify antibodies against the Cryptococcus neoformans fungus. This test is particularly important for individuals with compromised immune systems, such as those living with HIV/AIDS, as they are more susceptible to cryptococcal infections. Early detection through this test allows for prompt treatment and improved health outcomes.

This test measures the presence of antibodies produced by the immune system in response to a cryptococcal infection. A positive result suggests an active or past infection and requires further medical evaluation.

Individuals who may benefit from this test include those experiencing symptoms like persistent cough, fever, headache, or confusion, as well as immunocompromised patients (e.g., HIV/AIDS, cancer, immunosuppressive therapy) or those with a history of cryptococcal infections.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific patient preparation is required for this test. Confirm with the laboratory before booking.

Sample2 mL (0.5 mL minimum) serum collected in an SST tube.

MethodologyConfirm with the laboratory before booking.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects antibodies, which may indicate a past or present infection. It may not be positive in all cases of active infection, especially early on or in severely immunocompromised individuals. Results must be interpreted in the context of clinical presentation and other diagnostic findings. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Cryptococcosis is a fungal infection caused by Cryptococcus neoformans or Cryptococcus gattii. It most commonly affects the lungs and central nervous system.

Individuals with weakened immune systems are at higher risk, particularly those with HIV/AIDS, cancer, organ transplant recipients, or those taking immunosuppressive medications.

Symptoms can vary but often include fever, cough, shortness of breath, headache, confusion, or changes in mental status. Some people may have no symptoms.

A positive result indicates the presence of antibodies against the Cryptococcus fungus, suggesting a current or past infection. Further medical evaluation is necessary.

Treatment typically involves antifungal medications. The specific treatment plan depends on the location and severity of the infection and the patient's overall health.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp